BCG is the most common intravesical immunotherapy for treating early-stage bladder cancer. BCG is a vaccine made from a germ that's related to the one that causes tuberculosis (TB), …

Bacillus Calmette-Guérin (buh-SIH-lus KAL-met-gay-RIN) therapy is a type of immunotherapy that treats bladder tumors. It’s the most common kind of intravesical immunotherapy used to treat …

2023年5月22日 · Bacillus Calmette-Guerin (BCG) is the main intravesical immunotherapy for early-stage bladder cancer. It can help the immune system get rid of cancer cells in the bladder...

In a recent study, intravesical gemcitabine induced a lower rate of recurrence, progression and treatment failure than epirubicin or pirarubicin. 74 Furthermore, new multiagent intravesical …

For bladder cancer, BCG is given directly into the bladder (intravesical). This can make the bladder react in a way that makes the immune system get rid of cancer cells.

Bacillus Calmette–Guérin (BCG), a live attenuated strain of Mycobacterium bovis, is the most successful microbial immunotherapy of cancer in current use. Intravesical treatment with BCG …

The high recurrence and progression rates of non-muscle invasive bladder cancer (NMIBC) have led investigators to study the use of intravesical therapy in order to prevent them. Bacillus …

2024年4月26日 · BCG increases certain white blood cells that destroy invading tumor cells in the bladder. BCG is used to treat bladder cancer that is localized (has not spread to other parts of …

BCG (intravesical) is an attenuated strain of bacillus Calmette-Guérin (Mycobacterium bovis) used as a biological response modifier. BCG, when used intravesicularly for treatment of bladder …